Common Contracts
2 similar Merger Agreement contracts by Sorrento Therapeutics, Inc.
AGREEMENT OF MERGER by and among: SORRENTO THERAPEUTICS, INC., a Delaware corporation; CATALYST MERGER SUB, INC., a Delaware corporation; CONCORTIS BIOSYSTEMS, CORP., a Delaware corporation; and ZHENWEI MIAO and GANG CHEN Dated as of November 11, 2013Merger Agreement • November 14th, 2013 • Sorrento Therapeutics, Inc. • Services-commercial physical & biological research • Delaware
THIS AGREEMENT AND PLAN OF MERGER (“Agreement”) is made and entered into as of November 11, 2013, by and among: Sorrento Therapeutics, Inc., a Delaware corporation (“Parent”); Catalyst Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”); Concortis Biosystems, Corp., a Delaware corporation (the “Company”); and Zhenwei Miao and Gang Chen (each, a “Key Stockholder”). Certain other capitalized terms used in this Agreement are defined in Exhibit A.
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION among: SORRENTO THERAPEUTICS, INC., a Delaware corporation; SP MERGER SUB, INC., a Delaware corporation; SHERRINGTON PHARMACEUTICALS, INC., a Delaware corporation; ACERAS BIOMEDICAL LLC, a Delaware...Merger Agreement • October 15th, 2013 • Sorrento Therapeutics, Inc. • Services-commercial physical & biological research • Delaware
THIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (“Agreement”) is made and entered into as of October 9, 2013, by and among: Sorrento Therapeutics, Inc., a Delaware corporation (“Parent”); SP Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”); Sherrington Pharmaceuticals, Inc., a Delaware corporation (the “Company”); Aceras BioMedical LLC, a Delaware limited liability company (the “Key Holder”), the Company Stockholders and Cooley LLP, solely in its capacity as Escrow Agent. Certain other capitalized terms used in this Agreement are defined in Exhibit A.
